APDNX
Price
$15.63
Change
-$0.09 (-0.57%)
Updated
Sep 20 closing price
VITSX
Price
$136.99
Change
-$0.34 (-0.25%)
Updated
Sep 20 closing price
Ad is loading...

APDNX vs VITSX

Header iconAPDNX vs VITSX Comparison
Open Charts APDNX vs VITSXBanner chart's image
Artisan Select Equity Advisor
Price$15.63
Change-$0.09 (-0.57%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Market Idx I
Price$136.99
Change-$0.34 (-0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
APDNX vs VITSX Comparison Chart
Loading...
VS
APDNX vs. VITSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDNX is a StrongSell and VITSX is a Buy.

FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.72T vs. APDNX (51.8M). VITSX pays higher dividends than APDNX: VITSX (1.36) vs APDNX (0.51). APDNX was incepted earlier than VITSX: APDNX (5 years) vs VITSX (27 years). APDNX is a more actively managed with annual turnover of: 26.63 vs. VITSX (2.00). APDNX has a lower initial minimum investment than VITSX: APDNX (250000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 31.57 vs. APDNX (29.84).
APDNXVITSXAPDNX / VITSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years27 years-
Gain YTD16.12218.65186%
Front LoadN/AN/A-
Min. Initial Investment25000050000005%
Min. Initial Investment IRAN/AN/A-
Net Assets51.8M1.72T0%
Annual Yield % from dividends0.511.3637%
Returns for 1 year29.8431.5795%
Returns for 3 years16.4225.3665%
Returns for 5 yearsN/A85.68-
Returns for 10 yearsN/A188.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIPC42.450.13
+0.31%
Brookfield Infrastructure Corp
A140.09-1.86
-1.31%
Agilent Technologies
PHAT18.43-0.29
-1.55%
Phathom Pharmaceuticals
WTBA19.68-0.34
-1.70%
West Bancorporation
VTVT14.20-0.73
-4.89%
vTv Therapeutics